Federal Policy
CMS Reports 1.1 Million Enrollees in Medicare GLP-1 Bridge Pilot
HHS Chief Counselor Chris Klomp said roughly 1.1 million Medicare beneficiaries have enrolled in CMS's Bridge model, which offers discounted GLP-1 drugs at $50 per month to eligible Part D beneficiaries. The pilot launched July 1 and targets beneficiaries needing anti-obesity medication for reasons other than Type 2 diabetes, running through the end of 2027. CVS Health and Walgreens each reported dispensing more than 100,000 GLP-1 prescriptions through the program by late summer. CMS plans to begin sharing monthly utilization reports with Part D plans this fall so insurers can track member participation.
Why it mattersPart D plan sponsors and pharmacies need to plan for sustained GLP-1 utilization and cost exposure as CMS begins sharing enrollment data that will shape future coverage and pricing negotiations.